ProMRI Study of the Entovis Pacemaker System (Phase B)
Public ClinicalTrials.gov record NCT02009696. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02009696
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Biotronik, Inc.
- Industry
- Enrollment
- 221 participants
Conditions and interventions
Interventions
- Magnetic Resonance Imaging (MRI) scan Other
- Patients with a ProMRI Pacemaker System Device
Other · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2013
- Primary completion
- Oct 31, 2014
- Completion
- Dec 31, 2014
- Last update posted
- Nov 24, 2015
2013 – 2015
United States locations
- U.S. sites
- 32
- U.S. states
- 21
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85018 | — |
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Concord | California | 94520 | — |
| Not listed | Newport Beach | California | 92663 | — |
| Not listed | Rancho Mirage | California | 92270 | — |
| Not listed | New Haven | Connecticut | 06510 | — |
| Not listed | Newark | Delaware | 19702-5438 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Valparaiso | Indiana | 46383 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Lafayette | Louisiana | 70503 | — |
| Not listed | Cumberland | Maryland | 21502 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Burlington | Massachusetts | 01805 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Ypsilanti | Michigan | 48197 | — |
| Not listed | Kansas City | Missouri | 64132 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | The Bronx | New York | 10463 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Toledo | Ohio | 43615 | — |
| Not listed | Salem | Oregon | 97301 | — |
| Not listed | Newtown | Pennsylvania | 18940 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | Greenville | South Carolina | 29607 | — |
| Not listed | Amarillo | Texas | 79106 | — |
| Not listed | Mechanicsville | Virginia | 23116 | — |
| Not listed | Virginia Beach | Virginia | 23454 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02009696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2015 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02009696 live on ClinicalTrials.gov.